Cited 0 times in 
Cited 0 times in 
A Response to the Letter to the Editor Regarding "Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations
https://orcid.org/0000-0003-3490-2195Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.